Magellan Rx Management, a division of Magellan Health, Inc. , today released its fifth annual Medical Pharmacy Trend Report, the only industry benchmark of its kind to analyze high cost injectable drugs paid under the medical benefit.
from Content Keyword RSS http://ift.tt/1MFCm1j
via IFTTT
from Content Keyword RSS http://ift.tt/1MFCm1j
via IFTTT
No comments:
Post a Comment